Supplementary Figure S6 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model

<p>Effects of treatment with duvelisib and ibrutinib on the numbers of T cells in in mice receiving samples from the same patients in Figure 6.</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Shih-Shih Chen (15314296) (author)
Diğer Yazarlar:	Jacqueline C. Barrientos (15314299) (author), Gerardo Ferrer (15314302) (author), Morgan King-Richards (15314305) (author), Yu-Ju Chen (15314308) (author), Priyadarshini Ravichandran (15314311) (author), Michael Ibrahim (15314314) (author), Yasmine Kieso (15314317) (author), Sheila Waters (15314320) (author), Jeffery L. Kutok (15314323) (author), Marisa Peluso (15314326) (author), Sujata Sharma (15314329) (author), David T. Weaver (15314332) (author), Jonathan A. Pachter (15027774) (author), Kanti R. Rai (15314335) (author), Nicholas Chiorazzi (15314338) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Tumor Biology Therapeutic Research and Development Hematological Cancers Leukemias Small Molecule Agents Kinase inhibitors Tumor Microenvironment Immune cells and the microenvironment
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller